185 related articles for article (PubMed ID: 31471126)
1. Carcinoma ex pleomorphic adenoma: A review of incidence, demographics, risk factors, and survival.
Gupta A; Koochakzadeh S; Neskey DM; Nguyen SA; Lentsch EJ
Am J Otolaryngol; 2019; 40(6):102279. PubMed ID: 31471126
[TBL] [Abstract][Full Text] [Related]
2. [Carcinoma ex pleomorphic adenoma of major salivary glands--a clinicopathologic review].
Stodulski D; Rzepko R; Kowalska B; Stankiewicz C
Otolaryngol Pol; 2007; 61(5):687-93. PubMed ID: 18552001
[TBL] [Abstract][Full Text] [Related]
3. Survival and prognostic factors of salivary gland malignant mixed tumor-not otherwise specified: A population-based analysis.
Soffer JM; Nassif SJ; Von Plato M; Chisholm J; O'Leary MA
Am J Otolaryngol; 2021; 42(6):103135. PubMed ID: 34171696
[TBL] [Abstract][Full Text] [Related]
4. Predictors of survival in carcinoma ex pleomorphic adenoma.
Chen MM; Roman SA; Sosa JA; Judson BL
Head Neck; 2014 Sep; 36(9):1324-8. PubMed ID: 23956034
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for carcinoma ex pleomorphic adenoma in patients presenting with recurrence after resection of pleomorphic adenoma.
Yin LX; Van Abel KM; Rooker SA; Nagelschneider AA; Olsen KD; Price DL; Janus JR; Kasperbauer JL; Moore EJ
Head Neck; 2021 Feb; 43(2):419-427. PubMed ID: 33043539
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of carcinoma ex pleomorphic adenoma compared to de novo adenocarcinoma of major salivary glands.
Patel EJ; Oliver JR; Liu C; Tam M; Givi B
J Surg Oncol; 2021 Feb; 123(2):446-455. PubMed ID: 33145786
[TBL] [Abstract][Full Text] [Related]
7. Salivary gland pleomorphic adenoma in the Netherlands: A nationwide observational study of primary tumor incidence, malignant transformation, recurrence, and risk factors for recurrence.
Valstar MH; de Ridder M; van den Broek EC; Stuiver MM; van Dijk BAC; van Velthuysen MLF; Balm AJM; Smeele LE
Oral Oncol; 2017 Mar; 66():93-99. PubMed ID: 28249655
[TBL] [Abstract][Full Text] [Related]
8. Salivary Carcinosarcoma: An Extremely Rare and Highly Aggressive Malignancy.
Gupta A; Koochakzadeh S; Neskey DM; Nguyen SA; Lentsch EJ
Laryngoscope; 2020 May; 130(5):E335-E339. PubMed ID: 31291005
[TBL] [Abstract][Full Text] [Related]
9. The Difference in the Clinical Features Between Carcinoma ex Pleomorphic Adenoma and Pleomorphic Adenoma.
Seok J; Hyun SJ; Jeong WJ; Ahn SH; Kim H; Jung YH
Ear Nose Throat J; 2019 Sep; 98(8):504-509. PubMed ID: 31189352
[TBL] [Abstract][Full Text] [Related]
10. A 20-Year Review of 75 Cases of Salivary Duct Carcinoma.
Gilbert MR; Sharma A; Schmitt NC; Johnson JT; Ferris RL; Duvvuri U; Kim S
JAMA Otolaryngol Head Neck Surg; 2016 May; 142(5):489-95. PubMed ID: 26939990
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic Features and Prognostic Factors of Widely Invasive Carcinoma Ex Pleomorphic Adenoma of Parotid Gland: A Clinicopathologic Analysis of 126 Cases in a Chinese Population.
Hu Y; Xia L; Zhang C; Xia R; Tian Z; Li J
J Oral Maxillofac Surg; 2020 Dec; 78(12):2247-2257. PubMed ID: 32649893
[TBL] [Abstract][Full Text] [Related]
12. Cytological features of carcinoma ex pleomorphic adenoma of the salivary glands: A diagnostic challenge.
Okano K; Ishida M; Sandoh K; Fujisawa T; Iwai H; Tsuta K
Diagn Cytopathol; 2020 Feb; 48(2):149-153. PubMed ID: 31675185
[TBL] [Abstract][Full Text] [Related]
13. Risk of Carcinoma in Pleomorphic Adenomas of the Parotid.
Levyn H; Subramanian T; Eagan A; Katabi N; Lin O; Badillo ND; Martinez G; Scholfield DW; Wong RJ; Shah JP; Givi B; Morris LGT; Ganly I; Patel SG
JAMA Otolaryngol Head Neck Surg; 2023 Nov; 149(11):1034-1041. PubMed ID: 37824134
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcome of patients with carcinoma ex pleomorphic adenoma of the parotid gland: a comparative study from a single tertiary center.
Lim CM; Hobson C; Kim S; Johnson JT
Head Neck; 2015 Apr; 37(4):543-7. PubMed ID: 24677516
[TBL] [Abstract][Full Text] [Related]
15. Molecular Factors in Carcinoma Ex Pleomorphic Adenoma: Systematic Review and Meta-Analysis.
Key S; Chia C; Hasan Z; Sundaresan P; Riffat F; Dwivedi RC
Laryngoscope; 2024 Mar; 134(3):1042-1053. PubMed ID: 37610148
[TBL] [Abstract][Full Text] [Related]
16. Carcinoma ex pleomorphic adenoma of the submandibular gland: A retrospective analysis of 86 patients.
Liu S; Lu H; Liu L; Wu Y; Zhu Y; Xu W; Yang W; Zhang C
Oral Dis; 2023 May; 29(4):1602-1612. PubMed ID: 35199423
[TBL] [Abstract][Full Text] [Related]
17. Risk of breast cancer in women after a salivary gland carcinoma or pleomorphic adenoma in the Netherlands.
Valstar MH; Schaapveld M; van den Broek EC; van Velthuysen MF; de Ridder M; Schmidt MK; van Dijk BAC; Balm AJM; Smeele LE
Cancer Med; 2021 Jan; 10(1):424-434. PubMed ID: 33247629
[TBL] [Abstract][Full Text] [Related]
18. Systematic review of prognostic factors in carcinoma ex pleomorphic adenoma.
Key S; Chia C; Hasan Z; Sundaresan P; Dwivedi RC; Riffat F
Oral Oncol; 2022 Oct; 133():106052. PubMed ID: 35921695
[TBL] [Abstract][Full Text] [Related]
19. Carcinoma ex pleomorphic adenoma mimicking multiple facial nerve schwannoma.
Park KC; Choi HJ; Kwon JK
Auris Nasus Larynx; 2008 Jun; 35(2):291-4. PubMed ID: 17881169
[TBL] [Abstract][Full Text] [Related]
20. Carcinoma ex pleomorphic adenoma: pathologic analysis of 73 cases.
Lewis JE; Olsen KD; Sebo TJ
Hum Pathol; 2001 Jun; 32(6):596-604. PubMed ID: 11431714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
